Sandra Heskamp

4.3k citations
107 papers · 3.2k · 1 hit paper · h-index 32

Impact in

    • Radiopharmaceutical Chemistry and Applications
    • Medical Imaging Techniques and Applications
    • Monoclonal and Polyclonal Antibodies Research
  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Radiopharmaceutical Chemistry and Applications 44
    • Medical Imaging Techniques and Applications 15
    • Monoclonal and Polyclonal Antibodies Research 10
    • Cancer Immunotherapy and Biomarkers 14
    • CAR-T cell therapy research 10
    • Peptidase Inhibition and Analysis 9

Sandra Heskamp

104 papers receiving 3.1k citations

Sandra Heskamp's Hit Papers

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies 2023 · 138 citations
1380+1+2Years since publication4080120

Peers

Sandra Heskamp
Comparison fields: 5 of 109
  • Radiology, Nuclear Medicine and Imaging 1.5k
  • Oncology 1.1k
  • Pulmonary and Respiratory Medicine 947
  • Cancer Research 299
  • Immunology 316
Replace Carolina Pia Schroder with:
Carolina Pia Schroder Netherlands
Carolien P. Schröder Netherlands
Hanwen Zhang United States
Steve Y. Cho United States
C. Willemien Menke‐van der Houven van Oordt Netherlands
Richard Adam Messmann United States
Wouter Bastiaan Nagengast Netherlands
Gerben M. Franssen Netherlands
Mrudula Pullambhatla United States
Weijun Wei China
Sandra Heskamp relative to Carolina Pia Schroder Netherlands Carolina Pia Schroder's profile →
Citations per field
00.5×2×2.6×
Carolina Pia Schroder · 1×
Citations per year

Countries citing papers authored by Sandra Heskamp

Since Specialization
Citations

This map shows the geographic impact of Sandra Heskamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Heskamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Heskamp more than expected).

Fields of papers citing papers by Sandra Heskamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Heskamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Heskamp. The network helps show where Sandra Heskamp may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandra Heskamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Heskamp Line = papers co-authored together Sandra Heskamp links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2015206
2 2015186
3 2017166
4
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Hit paper breakdown →
2023138
5 2009128
6 2016107
7 2021107
8 201981
9 201981
10 202179
11 202179
12 201077
13 201977
14 201972
15 201968
16 201163
17 201856
18 202255
19 201454
20 201754

About Sandra Heskamp

Sandra Heskamp is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 107 papers that have together received 3.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (44 papers), Cancer, Hypoxia, and Metabolism (18 papers), Prostate Cancer Treatment and Research (18 papers), Medical Imaging Techniques and Applications (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.5k citations), Oncology (1.1k citations), Pulmonary and Respiratory Medicine (947 citations), Cancer Research (299 citations) and Immunology (316 citations). Sandra Heskamp has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Otto C. Boerman, Janneke D.M. Molkenboer‐Kuenen, Wim J.G. Oyen, Mark Rijpkema, Martin GOTTHARDT, Winette T. A van der Graaf, Johan Bussink, Gerben M. Franssen, Susanne Lütje and Hanneke W.M. van Laarhoven. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Theranostics, Journal of Nuclear Medicine, Molecular Pharmaceutics and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact